◆
BLACKSPECTER
AI Chat öffnen →
BlackSpecter
›
Aktien
›
CRSP
CRSP
(CRSP)
Kennzahlen
Marktkapitalisierung
n/a
KGV (TTM)
n/a
Umsatz (TTM)
n/a
EBITDA
n/a
Dividendenrendite
n/a
52W Hoch
n/a
52W Tief
n/a
Beta
n/a
EPS (TTM)
n/a
Forward KGV
n/a
PEG Ratio
n/a
Short-Quote
n/a
Analysten-Ratings
Keine Analysten-Daten verfügbar
Earnings
Keine Earnings-Daten verfügbar
Aktuelle News
GlobeNewswire
·
vor 1 Tagen
CRISPR Therapeutics Presents Phase 1a Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026
Zacks
·
vor 3 Tagen
Vertex Pharmaceuticals Up 15% in a Month: How to Play the Stock
Zacks
·
vor 5 Tagen
4 Gene-Editing Biotech Stocks Worth Watching for Long-Term Gains
Motley Fool
·
vor 8 Tagen
CRISPR Therapeutics Stock Is Up Only 8% This Year. Is Cathie Wood's Bet on the Gene-Editing Stock Dead Money?
MT Newswires
·
vor 25 Tagen
Crispr Therapeutics Posts "Quiet" Quarter as Casgevy Advances, SiRNA Data Readouts Near, RBC Says
Zacks
·
vor 25 Tagen
VRTX's Q2 Earnings Lag Estimates, Revenues Top, 2026 Sales View Raised
Frag BlackSpecter AI über CRSP
Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.
Ist CRSP kaufenswert?
CRSP Earnings Analyse
CRSP Bewertung
AI Chat öffnen →